NSCLC is the predominant form of lung cancer, often exhibiting resistance to chemotherapy. Thymol and citral have shown promise as anticancer agents in different cancer cell lines but have not been evaluated in combination against NSCLC. Hence, we planned to investigate the anticancer effect of thymol-citral combination and explore its mechanisms of action against A549 cells.
Methods
A549 cells were exposed to varying concentrations of thymol and citral, alone and in combination. Cell proliferation, plasma membrane integrity, apoptotic markers, reactive oxygen species (ROS) levels, cell cycle distribution, senescence induction, and migration potential were assessed. Additionally, in vitro safety was evaluated in human bronchial epithelial cells (HBECs) and human red blood cells (RBCs).
Results
Thymol and citral showed synergistic action against A549 cells, with a CI value of 0.75. After 24 h, they induced apoptosis, caused G0/G1 phase arrest, and increased ROS levels, suggesting oxidative stress as the mechanism. This combination also induced cell senescence, significantly inhibited A549 cell migration, and was non-toxic to human RBCs and HBECs.
Conclusion
Overall, the thymol-citral synergistic combination was found to be a safe and effective therapy option for non-small cell lung cancer.
Yu
Y.W.
Wang
C.P.
Han
Y.F.
Niu
J.J.
Zhang
Y.Z.
Fang
Y.
Meta-analysis on related risk factors regarding lung cancer in non-smoking Chinese women.
Zhonghua Liu Xing Bing Xue Za Zhi2016
37
2
268
272
10.3760/cma.j.issn.0254‑6450.2016.02.024
26917529
Azar
F.E.
Azami-Aghdash
S.
Pournaghi-Azar
F.
Mazdaki
A.
Rezapour
A.
Ebrahimi
P.
Yousefzadeh
N.
Cost-effectiveness of lung cancer screening and treatment methods: a systematic review of systematic reviews.
BMC Health Serv. Res.2017
17
1
413
10.1186/s12913‑017‑2374‑1
28629461
Nagao
S.
Kogiku
A.
Suzuki
K.
Shibutani
T.
Yamamoto
K.
Jimi
T.
Kitai
M.
Shiozaki
T.
Matsuoka
K.
Yamaguchi
S.
A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
J. Ovarian Res.2020
13
1
14
10.1186/s13048‑020‑0617‑y
32028974
Colomer
R.
Review of gemcitabine plus taxane combination therapy in the first-line treatment of metastatic breast cancer.
Eur. J. Cancer, Suppl.2008
6
8
9
12
10.1016/S1359‑6349(08)70284‑2
Pereira
J.R.
Fein
L.
del Giglio
A.
Blajman
C.R.
Richardet
E.
Schwartsmann
G.
Orlando
M.
Hall
B.J.
West
T.M.
van Kooten
M.
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancer.
Lung Cancer2007
58
1
80
87
10.1016/j.lungcan.2007.05.004
17588704
Mokhtari
R.B.
Homayouni
T.S.
Baluch
N.
Morgatskaya
E.
Kumar
S.
Das
B.
Yeger
H.
Combination therapy in combating cancer.
Oncotarget2017
8
23
38022
38043
10.18632/oncotarget.16723
28410237
Ozben
T.
Mechanisms and strategies to overcome multiple drug resistance in cancer.
FEBS Lett.2006
580
12
2903
2909
10.1016/j.febslet.2006.02.020
16497299
Nagoor Meeran
M.F.
Javed
H.
Al Taee
H.
Azimullah
S.
Ojha
S.K.
Pharmacological properties and molecular mechanisms of thymol: Prospects for its therapeutic potential and pharmaceutical development.
Front. Pharmacol.2017
8
380
10.3389/fphar.2017.00380
28694777
Kruk
I.
Michalska
T.
Lichszteld
K.
Kładna
A.
Aboul-Enein
H.Y.
The effect of thymol and its derivatives on reactions generating reactive oxygen species.
Chemosphere2000
41
7
1059
1064
10.1016/S0045‑6535(99)00454‑3
10879823
Sharma
S.
Habib
S.
Sahu
D.
Gupta
J.
Chemical Properties and Therapeutic Potential of Citral, a Monoterpene Isolated from Lemongrass.
Med. Chem.2021
17
1
2
12
10.2174/18756638MTAzbMjYa2
31880247
Chou
T.C.
Drug combination studies and their synergy quantification using the Chou-Talalay method.
Cancer Res.2010
70
2
440
446
10.1158/0008‑5472.CAN‑09‑1947
20068163
Yu
D.
Kahen
E.
Cubitt
C.L.
McGuire
J.
Kreahling
J.
Lee
J.
Altiok
S.
Lynch
C.C.
Sullivan
D.M.
Reed
D.R.
Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma.
Sci. Rep.2015
5
1
16991
10.1038/srep16991
26601688
Kiruthiga
C.
Jaya Balan
D.
Jafni
S.
Anandan
D.P.
Devi
K.P.
Phytol and (−)-α-bisabolol Synergistically trigger intrinsic apoptosis through redox and Ca2+ imbalance in non-small cell lung cancer.
Biocatal. Agric. Biotechnol.2024
56
103005
10.1016/j.bcab.2023.103005
Balan
D.J.
Rajavel
T.
Das
M.
Sathya
S.
Jeyakumar
M.
Devi
K.P.
Thymol induces mitochondrial pathway-mediated apoptosis via ROS generation, macromolecular damage and SOD diminution in A549 cells.
Pharmacol. Rep.2021
73
1
240
254
10.1007/s43440‑020‑00171‑6
33095436
Houghton
P.
Fang
R.
Techatanawat
I.
Steventon
G.
Hylands
P.J.
Lee
C.C.
The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity.
Methods2007
42
4
377
387
10.1016/j.ymeth.2007.01.003
17560325
Huh
S.
Ker
D.F.E.
Su
H.
Kanade
T.
Apoptosis detection for adherent cell populations in time-lapse phase-contrast microscopy images.
Med Image Comput Comput Assist Interv.2012
15
Pt 1
331
339
10.1007/978‑3‑642‑33415‑3_41
Kim
H.
Xue
X.
Detection of Total Reactive Oxygen Species in Adherent Cells by 2′,7′-Dichlorodihydrofluorescein Diacetate Staining.
J. Vis. Exp.2020
2020
160
10.3791/60682‑v
32658187
Itahana
K.
Campisi
J.
Dimri
G.P.
Methods to detect biomarkers of cellular senescence: the senescence-associated β-galactosidase assay.
Methods Mol. Biol.2007
371
21
31
10.1007/978‑1‑59745‑361‑5_3
17634571
Cappiello
F.
Casciaro
B.
Mangoni
M.L.
A novel in vitro wound healing assay to evaluate cell migration.
J. Vis. Exp.2018
2018
133
56825
10.3791/56825
29608162
do Vale
L.D.O.
da Silva
V.H.P.
de Almeida
F.R.
Ribeiro
D.A.
da Silva
D.M.
Evaluation of genotoxic and cytotoxic effects in buccal mucosa cells of welders in the cities of Cubatão and Santos, state of São Paulo, Brazil.
Rev. Bras. Med. Trab.2017
15
4
303
309
10.5327/Z1679443520170012
32377585
Pelicano
H.
Carney
D.
Huang
P.
ROS stress in cancer cells and therapeutic implications.
Drug Resist. Updat.2004
7
2
97
110
10.1016/j.drup.2004.01.004
15158766
Gentric
G.
Mieulet
V.
Mechta-Grigoriou
F.
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field.
Antioxid. Redox Signal.2017
26
9
462
485
10.1089/ars.2016.6750
27228792
Trachootham
D.
Alexandre
J.
Huang
P.
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Nat. Rev. Drug Discov.2009
8
7
579
591
10.1038/nrd2803
19478820
Althubiti
M.
Lezina
L.
Carrera
S.
Jukes-Jones
R.
Giblett
S.M.
Antonov
A.
Barlev
N.
Saldanha
G.S.
Pritchard
C.A.
Cain
K.
Macip
S.
Characterization of novel markers of senescence and their prognostic potential in cancer.
Cell Death Dis.2014
5
11
e1528
e1528
10.1038/cddis.2014.489
25412306
Nussbaumer
S.
Bonnabry
P.
Veuthey
J.L.
Fleury-Souverain
S.
Analysis of anticancer drugs: A review.
Talanta2011
85
5
2265
2289
10.1016/j.talanta.2011.08.034
21962644
Huang
C.Y.
Ju
D.T.
Chang
C.F.
Muralidhar Reddy
P.
Velmurugan
B.K.
A review on the effects of current chemotherapy drugs and natural agents in treating non–small cell lung cancer.
Biomedicine (Taipei)2017
7
4
23
10.1051/bmdcn/2017070423
29130448
Balusamy
S.R.
Perumalsamy
H.
Veerappan
K.
Huq
M.A.
Rajeshkumar
S.
Lakshmi
T.
Kim
Y.J.
Citral induced apoptosis through modulation of key genes involved in fatty acid biosynthesis in human prostate cancer cells: In silico and in vitro study.
BioMed Res. Int.2020
2020
1
15
10.1155/2020/6040727
32258129
Kubatka
P.
Uramova
S.
Kello
M.
Kajo
K.
Samec
M.
Jasek
K.
Vybohova
D.
Liskova
A.
Mojzis
J.
Adamkov
M.
Zubor
P.
Smejkal
K.
Svajdlenka
E.
Solar
P.
Samuel
S.M.
Zulli
A.
Kassayova
M.
Lasabova
Z.
Kwon
T.K.
Pec
M.
Danko
J.
Büsselberg
D.
Anticancer Activities of Thymus vulgaris L. in experimental breast carcinoma in vivo and in vitro.
Int. J. Mol. Sci.2019
20
7
1749
10.3390/ijms20071749
30970626
Kyakulaga
A.H.
Aqil
F.
Munagala
R.
Gupta
R.C.
Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells.
Oncotarget2020
11
16
1399
1416
10.18632/oncotarget.27519
32362998
Kiruthiga
C.
Jaya
D.
Nagaiah
B.
Prasath
H.
Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles.
Naunyn Schmiedebergs Arch Pharmacol.2024
397
7
5131
5144
10.1007/s00210‑023‑02935‑2
Kiruthiga
C.
Niharika
K.
Devi
K.P.
Phytol and α-Bisabolol Synergy Induces Autophagy and Apoptosis in A549 Cells and Additional Molecular Insights through Comprehensive Proteome Analysis via Nano LC-MS/MS.
Anticancer. Agents Med. Chem.2024
24
10
773
788
10.2174/0118715206289038240214102951
38415491
Zhao
C.
Gao
W.
Chen
T.
Synergistic induction of apoptosis in A549 cells by dihydroartemisinin and gemcitabine.
Apoptosis2014
19
4
668
681
10.1007/s10495‑013‑0953‑0
24337869
Hu
S.
Li
X.
Xu
R.
Ye
L.
Kong
H.
Zeng
X.
Wang
H.
Xie
W.
The synergistic effect of resveratrol in combination with cisplatin on apoptosis via modulating autophagy in A549 cells.
Acta Biochim. Biophys. Sin. (Shanghai)2016
48
6
528
535
10.1093/abbs/gmw026
27084520
Vajrabhaya
L.
Korsuwannawong
S.
Cytotoxicity evaluation of a Thai herb using tetrazolium (MTT) and sulforhodamine B (SRB) assays.
J. Anal. Sci. Technol.2018
9
1
15
10.1186/s40543‑018‑0146‑0
Rubinstein
L.V.
Shoemaker
R.H.
Paull
K.D.
Simon
R.M.
Tosini
S.
Skehan
P.
Scudiero
D.A.
Monks
A.
Boyd
M.R.
Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
J. Natl. Cancer Inst.1990
82
13
1113
1117
10.1093/jnci/82.13.1113
2359137
Skehan
P.
Storeng
R.
Scudiero
D.
Monks
A.
McMahon
J.
Vistica
D.
Warren
J.T.
Bokesch
H.
Kenney
S.
Boyd
M.R.
New colorimetric cytotoxicity assay for anticancer-drug screening.
J. Natl. Cancer Inst.1990
82
13
1107
1112
10.1093/jnci/82.13.1107
2359136
Aydın
E.
Türkez
H.
In vitro cytotoxicity, genotoxicity and antioxidant potentials of thymol on human blood cells.
J. Essent. Oil Res.2014
26
2
133
140
10.1080/10412905.2013.860411
Fulda
S.
Gorman
A.M.
Hori
O.
Samali
A.
Cellular stress responses: cell survival and cell death.
Int. J. Cell Biol.2010
2010
1
23
10.1155/2010/214074
20182529
Kapur
A.
Felder
M.
Fass
L.
Kaur
J.
Czarnecki
A.
Rathi
K.
Zeng
S.
Osowski
K.K.
Howell
C.
Xiong
M.P.
Whelan
R.J.
Patankar
M.S.
Modulation of oxidative stress and subsequent induction of apoptosis and endoplasmic reticulum stress allows citral to decrease cancer cell proliferation.
Sci. Rep.2016
6
1
27530
10.1038/srep27530
27270209
Li
Y.
Wen
J.
Du
C.
Hu
S.
Chen
J.
Zhang
S.
Zhang
N.
Gao
F.
Li
S.
Mao
X.
Miyamoto
H.
Ding
K.
Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis.
Biochem. Biophys. Res. Commun.2017
491
2
530
536
10.1016/j.bbrc.2017.04.009
28389245
Carrasco-Torres
G.
Baltiérrez-Hoyos
R.
Andrade-Jorge
E.
Villa-Treviño
S.
Trujillo-Ferrara
J.G.
Vásquez-Garzón
V.R.
Cytotoxicity, Oxidative Stress, Cell Cycle Arrest, and Mitochondrial Apoptosis after Combined Treatment of Hepatocarcinoma Cells with Maleic Anhydride Derivatives and Quercetin.
Oxid. Med. Cell. Longev.2017
2017
1
2734976
10.1155/2017/2734976
29163752
Ohshima
K.
Morii
E.
Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis.
Metabolites2021
11
1
28
10.3390/metabo11010028
33401771
Gkretsi
V.
Stylianopoulos
T.
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell Invasion and Metastasis.
Front. Oncol.2018
8
145
10.3389/fonc.2018.00145
29780748
Nordin
N.
Yeap
S.K.
Rahman
H.S.
Zamberi
N.R.
Abu
N.
Mohamad
N.E.
How
C.W.
Masarudin
M.J.
Abdullah
R.
Alitheen
N.B.
In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
Sci. Rep.2019
9
1
1614
10.1038/s41598‑018‑38214‑x
30733560
Lv
R.
Chen
Z.
Thymol inhibits cell migration and invasion by downregulating the activation of PI3K/AKT and ERK pathways in human colon cancer cells.
Trop. J. Pharm. Res.2018
16
12
2895
10.4314/tjpr.v16i12.13
Farag
M.R.
Alagawany
M.
Erythrocytes as a biological model for screening of xenobiotics toxicity.
Chem. Biol. Interact.2018
279
73
83
10.1016/j.cbi.2017.11.007
29128605
Pagano
M.
Faggio
C.
The use of erythrocyte fragility to assess xenobiotic cytotoxicity.
Cell Biochem. Funct.2015
33
6
351
355
10.1002/cbf.3135
26399850
Tadin
A.
Stazic
V.
Galic
N.
Zeljezic
D.
Evaluation of cytotoxic and genotoxic effects in buccal mucosal cells in non-smokers and users of traditional combustible tobacco products and non-combustible alternatives.
J. Xenobiot.2024
14
1
154
165
10.3390/jox14010009
38249106